Christopher Garrett
About
In The Last Decade
Christopher Garrett
13 papers receiving 262 citations
Peers
Comparison fields: 5 of 56
- Oncology 95
- Immunology 85
- Epidemiology 70
- Endocrinology, Diabetes and Metabolism 45
- Emergency Medicine 44
Countries citing papers authored by Christopher Garrett
This map shows the geographic impact of Christopher Garrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Garrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Garrett more than expected).
Fields of papers citing papers by Christopher Garrett
This network shows the impact of papers produced by Christopher Garrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Garrett. The network helps show where Christopher Garrett may publish in the future.
Co-authorship network of co-authors of Christopher Garrett
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Garrett. A scholar is included among the top collaborators of Christopher Garrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Garrett. Christopher Garrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 47 | |
| 4 | 6 | |
| 5 | 0 | |
| 6 | Feasibility and Acceptability of Robot Assistant in Self-management of Type 1 Diabetes in Children | 5 |
| 7 | 1 | |
| 8 | 107 | |
| 9 | 6 | |
| 10 | 15 | |
| 11 | Expression of epiregulin and amphiregulin and K-RAS mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab (Erbitux ®) | 3 |
| 12 | 68 | |
| 13 | 7 | |
| 14 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.